Skip to content
       Former Invitrogen and GE Executive Replaces Retired Company COO

CHICAGO, April 24 /PRNewswire-FirstCall/ — Allscripts (Nasdaq: MDRX), the
leading provider of clinical software, connectivity and information solutions
that physicians use to improve healthcare, announced today that Benjamin
Bulkley has joined the company as Chief Operating Officer. Mr. Bulkley brings
to the position more than 20 years of operational experience in a variety of
senior leadership roles.

(Logo: )

Mr. Bulkley was most recently Senior Vice President of Global Commercial
Operations for Invitrogen Corporation, a provider of essential life science
technologies for disease research and drug discovery, where he led the effort
to build the company’s global client base through innovative scientific and
distribution initiatives. Invitrogen globally employs approximately 4,300
scientists and other professionals and had revenues of more than $1.26 billion
in 2006.

“Ben’s exemplary leadership experience, broad knowledge of the healthcare
industry within both the information technology and life science markets, and
focus on operational excellence will help Allscripts deliver world class
service for our clients and develop new revenue opportunities,” said Glen
Tullman, Chief Executive Officer of Allscripts.

Prior to joining Invitrogen in October, 2003, Mr. Bulkley spent 16 years
at General Electric, most recently as Vice President of Global Services for
GE’s Medical Systems Information Technologies division. In that position, he
led a 1,500-person global service business, including service operations,
clinical project management, parts/supplies distribution, and marketing and
sales around the world. Prior to that, Mr. Bulkley held the position of
General Manager of Global Marketing and was responsible for leading 150-person
regional marketing teams, supporting sales growth, helping create integrated
product plans, and establishing and integrating the business identity across
multiple acquisitions.

Mr. Bulkley has served on the Board of Directors of the California
Healthcare Institute, The Analytical and Life Science Systems Association
(ALSSA), and also San Diego’s CONNECT. He holds a Bachelor of Science degree
in Electrical Engineering from the University of Connecticut and a Master of
Science degree in Engineering from Gannon University in Pennsylvania.

“I am excited to be joining the senior leadership team of a company that I
have admired for many years,” said Mr. Bulkley. “Allscripts is clearly the
market leader for Electronic Health Records, the hottest part of the market
today, and has a clear vision of how software and technology can inform,
connect and transform the future of healthcare. My goal is to help Allscripts
deliver on that vision with solid results.”

Mr. Bulkley replaces Joseph Carey, the previous Chief Operating Officer,
who recently announced his intention to retire from Allscripts, after serving
in a variety of executive positions over the last 13 years in companies led by
Mr. Tullman.

About Allscripts

Allscripts is the leading provider of clinical software, connectivity and
information solutions that physicians use to improve healthcare. The Company’s
business units provide unique solutions that inform, connect and transform
healthcare. Allscripts award-winning software applications include electronic
health records, practice management, e-prescribing, document imaging,
emergency department, and care management solutions, all offered through the
Company’s Clinical Solutions units. Additionally, Allscripts provides clinical
product education and connectivity solutions for physicians and patients
through its Physicians Interactive(TM) unit, and medication fulfillment
services through its Medication Services unit. To learn more, visit Allscripts
on the Web at

This announcement may contain forward-looking statements about Allscripts
Healthcare Solutions that involve risks and uncertainties. These statements
are developed by combining currently available information with Allscripts
beliefs and assumptions. Forward-looking statements do not guarantee future
performance. Because Allscripts cannot predict all of the risks and
uncertainties that may affect it, or control the ones it does predict,
Allscripts’ actual results may be materially different from the results
expressed in its forward-looking statements. For a more complete discussion of
the risks, uncertainties and assumptions that may affect Allscripts, see the
Company’s 2006 Annual Report on Form 10-K, available through the Web site
maintained by the Securities and Exchange Commission at

SOURCE  Allscripts
    -0-                             04/24/2007
    /CONTACT:  Dan Michelson, Chief Marketing Officer +1-312-506-1217,, or Todd Stein, Senior Manager-Public Relations,
+1-312-506-1216,, both of Allscripts/
         AP Archive:
         PRN Photo Desk, /
    /Web site: /

CO:  Allscripts
ST:  Illinois

-- AQTU024A --
3119 04/24/2007 09:30 EDT
Scroll To Top